50/50 Split: BioNTech and the Pfizer Illusion
SHARE | PRINT | EMAIL
Why is there so much focus on Pfizer in public discussion of the Covid vaccine market, virtually to the exclusion of BioNTech and even in discussion by seasoned... Read more.
EU Renews Digital Covid Pass Despite 99% Negative Public Feedback
SHARE | PRINT | EMAIL
The certificate regulation was originally adopted in June of last year, ostensibly to facilitate “safe travel” between EU member states. But the EU digital certificate... Read more.
EU Goes All-In on mRNA Vaccines, Reserves Capacity for Next Pandemic
SHARE | PRINT | EMAIL
The tender announcement and related documents mention three different sorts of novel vaccines: mRNA, protein, and vector-based. But in light of the EU’s Covid-19... Read more.
French President Macron: “Vaccinate Everything That Can Be Vaccinated”
SHARE | PRINT | EMAIL
“Vaccinate everything that can be vaccinated,” Macron said, “because we avoid the virus. That’s the best response for unburdening the healthcare system and... Read more.
After Summer, Europe to Target the Unvaccinated
SHARE | PRINT | EMAIL
The European Commission’s April 27th documents thus clearly invoke a new rollout of the Covid-19 vaccination campaign in the fall, specifically targeting the hitherto... Read more.
How Germany’s Crazy New Rules Punish Natural Immunity
SHARE | PRINT | EMAIL
In what must be one of the most mind-bending public health measures adopted anywhere in the world during the entire Covid-19 pandemic, Germany recently reduced the... Read more.
The Pfizer/BioNTech Vaccine Monopoly: The Backstory
SHARE | PRINT | EMAIL
For all the talk of the power of Big Pharma, the Covid-19 vaccine that is currently becoming the standard throughout the Western world has a far more powerful state... Read more.